Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cardiotoxicity × Biomarkers × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 2 Uterine Neoplasms 1 Stomach Neoplasms 1 Obesity 1 Neoplasms 1 Motor Activity 1 Cardiotoxicity 1

Interventions

Exercise 6 salicylhydroxamic acid 2 High-Intensity Interval Training 2 Echocardiography 2 sacubitril and valsartan sodium hydrate drug combination 1 mitoquinone 1 epicatechin gallate 1 candesartan 1 Therapeutics 1 Secondary Prevention 1 Restraint, Physical 1 Rehabilitation 1 Proton Therapy 1 Proteins 1 Palliative Care 1 Methods 1 Medical History Taking 1 Magnetic Resonance Spectroscopy 1 Laser-Doppler Flowmetry 1 Ivabradine 1 Heart Rate 1 Heart Function Tests 1 Exercise Test 1 Electrocardiography 1 Echocardiography, Stress 1 Blood Pressure 1 Blood Cell Count 1 Biomarkers 1 Anthropometry 1 Anthracyclines 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02605512 2023-11-08

BACCARAT

Institut de Radioprotection et de Surete Nucleaire

Phase NA Completed

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡